EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity

Tirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, Akash Srivaths, Maede Salehi, Gokhan Gunay, Chloe Gerak, Liam Neil, Oliver Ozaydin, Olivia Voulgaris, Aleen Al Halawani, Dáire Gannon und 16 weitere

Cell Reports · 2026-01 · 45 (1) · 116665

DOI: 10.1016/j.celrep.2025.116665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Tirta M Djajawi und 27 weiteren Autor:innen. Beteiligte Einrichtung: Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, A…. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinases, Neoplasms, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Snow Medical, Tour de Cure, Nile Albright Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MAP Kinase Kinase KinasesNeoplasmsCytokinesAnimalsMiceHumansCD8-Positive T-LymphocytesInterferon-gammaMice, Inbred C57BLSignal TransductionApoptosisCell Line, TumorTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

CP: cancerCP: immunologyCRISPRTAK1TNFcFLIPimmunotherapyinterferon gamma

Substanzen

MAP Kinase Kinase KinasesInterferon-gammaCytokinesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.
  • The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
  • Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia; The Walter and Eliza Hall Institute of Medical Research, Par…
  • Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
  • The Peter MacCallum Cancer Centre, Parkville, VIC 3052, Australia.
  • The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia. Electronic address: vervoort.s@wehi.edu.au.

Förderung

  • Snow Medical
  • Tour de Cure
  • Nile Albright Research Foundation
  • CSL Limited
  • Cass Foundation
  • Olivia Newton-John Cancer Research Institute
  • National Health and Medical Research Council

Zitieren

APA

Djajawi, T. M., Huber, A., Rivera, S. M., Srivaths, A., Salehi, M., Gunay, G., Gerak, C., Neil, L., Ozaydin, O., Voulgaris, O., Al Halawani, A., Gannon, D., Khoshdoozmasouleh, N., Jenkins, L. J., Chan, K. F., Behren, A., Ernst, M., Mielke, L. A., Lelliott, E. J., …, & Kearney, C. J. (2026). A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. Cell Reports, 45(1), 116665. https://doi.org/10.1016/j.celrep.2025.116665

Vancouver

Djajawi TM, Huber A, Rivera SM, Srivaths A, Salehi M, Gunay G, et al. A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. Cell Reports. 2026;45(1):116665. doi:10.1016/j.celrep.2025.116665

BibTeX
@article{Djajawi2026,
  author = {Djajawi, Tirta M and Huber, Anne and Rivera, Sarahi Mendoza and Srivaths, Akash and Salehi, Maede and Gunay, Gokhan and Gerak, Chloe and Neil, Liam and Ozaydin, Oliver and Voulgaris, Olivia and Al Halawani, Aleen and Gannon, Dáire and Khoshdoozmasouleh, Nooshin and Jenkins, Laura J and Chan, Kok Fei and Behren, Andreas and Ernst, Matthias and Mielke, Lisa A and Lelliott, Emily J and Dong, Hao and Feltham, Rebecca and Sutton, Vivien R and Trapani, Joseph A and Mariadason, John M and Pal, Bhupinder and Martin, Seamus J and Vervoort, Stephin J and Kearney, Conor J},
  title = {A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {1},
  pages = {116665},
  doi = {10.1016/j.celrep.2025.116665}
}
Kostenlos starten →